VRDN smart money
Viridian Therapeutics, INC.\de (VRDN): 2 insider buys, 9 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$30.0M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-05-13 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | $20.0M | $17.0 |
| 2025-10-27 | Fairmount Healthcare Fund II Gp LLC | Director,TenPercentOwner | $10.0M | $22.0 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 2 | Venrock Adviser, LLC | 3.26% | $67M | |
| 3 | Fairmount Funds Management LLC | 6.57% | $105M | |
| 10 | Paradigm Biocapital Advisors LP | ADD +23% | 3.38% | $170M |
| 30 | Deep Track Capital, LP | TRIM -52% | 0.59% | $35M |
| 31 | Affinity Asset Advisors, LLC | 0.30% | $5M | |
| 60 | Kynam Capital Management, LP | TRIM -5% | 7.01% | $127M |
| 74 | First Turn Management, LLC | TRIM -9% | 4.17% | $31M |
| 80 | Avoro Capital Advisors LLC | 0.53% | $52M | |
| 83 | Tri Locum Partners LP | BUY | 0.37% | $2M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Biotech ETF | ADD | +$23M | 2026-06-30 |